The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anlotinib plus TQB2450 in patients with advanced refractory biliary tract cancer (BTC): An open-label, dose-escalating, and dose-expansion cohort of phase Ib trial.
 
Jun Zhou
No Relationships to Disclose
 
Jifang Gong
No Relationships to Disclose
 
Yanshuo Cao
No Relationships to Disclose
 
Zhi Peng
No Relationships to Disclose
 
Jiajia Yuan
No Relationships to Disclose
 
Xicheng Wang
No Relationships to Disclose
 
Ming LU
No Relationships to Disclose
 
Lin Shen
No Relationships to Disclose